Pyridostigminedrug info
pyridostigmine bromide 30 MG Oral Tablet
What it is used for
Pyridostigmine bromide is indicated for pretreatment against the lethal effects of soman nerve agent poisoning in adults. Pyridostigmine bromide is intended for use in conjunction with protective garments, including a mask. At the first sign of nerve agent poisoning, pyridostigmine bromide should be stopped, and atropine and pralidoxime therapy started immediately. The evidence for the effectiveness of pyridostigmine bromide as pretreatment against soman-induced toxicity was derived from animal studies alone. FOR MILITARY MEDICAL USE ONLY Pyridostigmine bromide is a cholinesterase inhibitor indicated for pretreatment against the lethal effects of soman nerve agent poisoning in adults. Pyridostigmine bromide is for use in conjunction with: Protective garments, including a gas mask, and Immediate atropine and pralidoxime therapy at the first sign of nerve agent poisoning.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective December 23, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
Description
Pyridostigmine bromide is an orally active, reversible cholinesterase inhibitor. Pyridostigmine bromide is a white or almost white, crystalline, deliquescent powder, very soluble in water and alcohol, and practically insoluble in ether. CAS registration number is 101-26-8. Pyridostigmine bromide has a molecular formula of C 9 H 13 BrN 2 O 2, with a molecular weight of 261.12.
Its chemical name is: 3-hydroxy-1-methylpyridinium bromide dimethylcarbamate, and its structural formula is: Pyridostigmine bromide tablets, USP contain 30 mg of pyridostigmine bromide (equivalent to 20.8 mg of pyridostigmine base) for oral administration. The inactive ingredients included in the tablet formula are colloidal silicon dioxide, lactose anhydrous, and stearic acid or, alternatively; lactose, magnesium stearate, silica precipitated, starch, and talc. Chemical Structure
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective December 23, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance